VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 122 filers reported holding VERVE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $262,349 | -83.5% | 19,785 | -76.7% | 0.00% | -100.0% |
| Q2 2023 | $1,592,325 | -28.6% | 84,924 | -45.1% | 0.00% | 0.0% |
| Q1 2023 | $2,229,188 | +733.8% | 154,590 | +1018.9% | 0.00% | – |
| Q4 2022 | $267,340 | -4.9% | 13,816 | +12.0% | 0.00% | – |
| Q1 2022 | $281,000 | -84.2% | 12,333 | -74.4% | 0.00% | -100.0% |
| Q4 2021 | $1,775,000 | +210.3% | 48,137 | +407.1% | 0.00% | – |
| Q2 2021 | $572,000 | – | 9,492 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alphabet Inc. | 10,974,011 | $515,778,000 | 12.24% |
| Casdin Capital, LLC | 3,038,167 | $142,794,000 | 3.55% |
| Redmile Group, LLC | 1,869,030 | $87,844,000 | 1.53% |
| Logos Global Management LP | 443,265 | $20,833,000 | 1.50% |
| Novo Holdings A/S | 600,000 | $28,200,000 | 1.46% |
| Cormorant Asset Management, LP | 709,224 | $32,667,000 | 1.33% |
| Rock Springs Capital Management LP | 962,826 | $45,253,000 | 0.95% |
| HighVista Strategies LLC | 18,782 | $883,000 | 0.58% |
| RA Capital Management | 880,284 | $41,373,000 | 0.57% |
| Nicholas Investment Partners, LP | 132,300 | $6,218,000 | 0.45% |